IP Library Granted Patent US 8,216,573
Granted Patent B2
US 8,216,573 · App. 11/859,200 · Granted Jul 10, 2012

Process for the fermentative production of antibodies

Assignee: Wacker Chemie AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,216,573
App. No.
11/859,200
Granted
Jul 10, 2012
Kind
B2
Abstract

The present invention relates to a process for producing a correctly folded and assembled full-length antibody using an E. coli strain, which comprises fermenting an E. coli strain which leaks periplasmic proteins into the medium, comprising a gene coding for the heavy chain of an antibody functionally linked to a signal sequence coding for a signal peptide, and a second gene coding for the light chain of an antibody, functionally linked to a signal sequence coding for a signal peptide, in a culture medium, where the E. coli strain secretes a full-length antibody into the culture medium, and the full-length antibody is removed from the culture medium.

Claims (17)

1. A method for producing a correctly folded and assembled full-length antibody using an E. coli strain, the method comprising: a) fermenting in a culture medium an E. coli strain which leaks periplasmic proteins into a medium, the E. coli strain comprising: a gene coding for a heavy chain of an antibody functionally linked to a signal sequence coding for a signal peptide; and a second gene coding for the light chain of an antibody, functionally linked to a signal sequence coding for a signal peptide, wherein the E. coli strain secretes a full-length antibody into a culture medium and wherein the leaky mutant is an E. coli strain selected from the group consisting of JF733, A592, A593, A586, CAG12184, G11e1, JE5511, E610, E623, JE5505, PM61, 6628, PM61R, JP1228, 207, and AE84064; and b) removing the full-length antibody from the culture medium.

2. The method of claim 1 , wherein the antibody is obtained in a yield of greater than 160 mg/l without coexpression of a periplasmic chaperone.

3. The method of claim 1 , wherein the signal sequence coding for a signal peptide is selected from the group consisting of the signal sequences of the phoA or ompA gene of E. coli or the signal sequence having sequence SEQ ID No: 1.

4. The method of claim 1 , wherein the 5′ ends of the genes of the light and heavy chain are linked in frame to different signal sequences coding for a signal peptide.

5. The method of claim 4 , wherein the 5′ end of the gene coding for the one chain of the antibody is functionally linked in frame to the signal sequence of the phoA or ompA gene of E. coli , and the 5′ end of the gene coding for the other chain of the antibody is linked in frame to the signal sequence SEQ ID No: 1.

6. The method of claim 1 , wherein the gene coding for the heavy chain of an antibody functionally linked to a signal sequence coding for a signal peptide, and the second gene coding for the light chain of an antibody, functionally linked to a signal sequence coding for a signal peptide, are combined in one operon.

7. The method of claim 1 , wherein fermentation takes place over a period of 16 to 150 hours.

8. The method of claim 1 , wherein the fermentation takes place with an oxygen partial pressure (pO 2 ) of between 10 and 70% saturation.

9. The method of claim 1 , wherein the fermentation takes place with an oxygen partial pressure (pO 2 ) of between 30 and 60% saturation.

10. The method of claim 1 , wherein the fermentation takes place with an oxygen partial pressure (pO 2 ) of between 45 and 55% saturation.

11. The method of claim 1 , wherein the pH in the culture medium is between pH 6 and pH 8.

12. The method of claim 1 , wherein the pH in the culture medium is between pH 6.5 and 7.5.

13. The method of claim 1 , wherein the temperature before induction of gene expression is reduced from 30° C. to 25° C. to prevent formation of inclusion bodies.

14. The method of claim 1 , wherein the removal of the full-length antibodies from the culture medium comprises:

separating the antibodies by centrifugation or filtration,

concentrating the antibodies by ultrafiltration; and

purifying the antibodies by precipitation, chromatography or ultrafiltration or affinity chromatography.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2007
From: WICH, GUENTER; DASSLER, TOBIAS
To: WACKER CHEMIE AG
Reel/Frame 019890/0548 →
Priority Claims (1)
EP 06121093 · Sep 22, 2006 · regional
Continuity (1)
Related Publication 20080206818A1 · Aug 28, 2008